BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38036453)

  • 1. Mechanisms of infantile epileptic spasms syndrome: What have we learned from animal models?
    Ng AC; Choudhary A; Barrett KT; Gavrilovici C; Scantlebury MH
    Epilepsia; 2024 Feb; 65(2):266-280. PubMed ID: 38036453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical Parvalbumin-Positive Interneuron Development and Function Are Altered in the APC Conditional Knockout Mouse Model of Infantile and Epileptic Spasms Syndrome.
    Ryner RF; Derera ID; Armbruster M; Kansara A; Sommer ME; Pirone A; Noubary F; Jacob M; Dulla CG
    J Neurosci; 2023 Feb; 43(8):1422-1440. PubMed ID: 36717229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Advancements in Infantile Epileptic Spasms Syndrome and Opportunities for Precision Medicine.
    Snyder HE; Jain P; RamachandranNair R; Jones KC; Whitney R
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Landscape of genetic infantile epileptic spasms syndrome-A multicenter cohort of 124 children from India.
    Nagarajan B; Gowda VK; Yoganathan S; Sharawat IK; Srivastava K; Vora N; Badheka R; Danda S; Kalane U; Kaur A; Madaan P; Mehta S; Negi S; Panda PK; Rajadhyaksha S; Saini AG; Saini L; Shah S; Srinivasan VM; Suthar R; Thomas M; Vyas S; Sankhyan N; Sahu JK
    Epilepsia Open; 2023 Dec; 8(4):1383-1404. PubMed ID: 37583270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional vitamin B12 deficiency-associated Infantile epileptic spasms syndrome: Clinico-neurophysiological presentation, response to treatment, and neurodevelopmental outcome.
    Sharawat IK; Ramachandran A; Elwadhi A; Tomar A; Panda PK
    Seizure; 2023 Aug; 110():93-98. PubMed ID: 37331199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epileptic spasms relapse is associated with response latency but not conventional attributes of post-treatment EEG.
    Deckard E; Sathe R; Tabibzadeh D; Terango A; Groves A; Rajaraman RR; Nariai H; Hussain SA
    Epilepsia Open; 2024 Jun; 9(3):1034-1041. PubMed ID: 38588009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype.
    Kenney-Jung DL; Rogers DJ; Kroening SJ; Zatkalik AL; Whitmarsh AE; Roberts AE; Zenker M; Gambardella ML; Contaldo I; Leoni C; Onesimo R; Zampino G; Tartaglia M; Battaglia DI; Pierpont EI
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):501-509. PubMed ID: 36448195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term analysis of adrenocorticotropic hormone monotherapy for infantile epileptic spasms syndrome with periventricular leukomalacia.
    Matsuura R; Hamano SI; Hirata Y; Takeda R; Takeuchi H; Koichihara R; Kikuchi K; Oka A
    Seizure; 2023 Jul; 109():40-44. PubMed ID: 37207538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta-analysis.
    Xu Z; Gong P; Jiao X; Niu Y; Wu Y; Zhang Y; Chang X; Yang Z
    Epilepsia Open; 2023 Jun; 8(2):268-277. PubMed ID: 36740237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studies.
    Galanopoulou AS; Moshé SL
    Neurobiol Dis; 2015 Jul; 79():135-49. PubMed ID: 25968935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review.
    Prezioso G; Chiarelli F; Matricardi S
    Expert Rev Neurother; 2023; 23(7):661-671. PubMed ID: 37243682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials.
    Osborne JP; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick A; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; O'Callaghan FK
    Eur J Paediatr Neurol; 2023 Jan; 42():110-116. PubMed ID: 36621063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying risk factors for adverse events of pyridoxal phosphate in infantile epileptic spasms syndrome.
    Arai Y; Okanishi T; Kanai S; Ohta K; Sunada H; Noma H; Maegaki Y
    Epilepsy Behav; 2023 Aug; 145():109348. PubMed ID: 37459718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical mechanisms in pathogenesis of infantile epileptic spasm syndrome.
    Riikonen R
    Seizure; 2023 Feb; 105():1-9. PubMed ID: 36634586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fifteen years of real-world data on the use of vigabatrin in individuals with infantile epileptic spasms syndrome.
    Kuchenbuch M; Lo Barco T; Chemaly N; Chiron C; Nabbout R
    Epilepsia; 2024 Feb; 65(2):430-444. PubMed ID: 37872396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing the clinical onset of epileptic spasms in infantile epileptic spasms syndrome: A tertiary health center's experience.
    Hadjinicolaou A; Briscoe Abath C; Singh A; Donatelli S; Salussolia CL; Cohen AL; He J; Gupta N; Merchant S; Zhang B; Olson H; Yuskaitis CJ; Libenson MH; Harini C
    Epilepsia; 2024 Apr; 65(4):984-994. PubMed ID: 38317356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cohort study of infantile epileptic spasms syndrome: etiological analysis and treatment of corticosteroids.
    Jiang Y; Zou N; Luo Y; Cheng M; Liao S; Hong S; Liang X; Zhong M; Li T; Jiang L
    Seizure; 2022 Oct; 101():120-126. PubMed ID: 35952490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early transient dysautonomia predicts the risk of infantile epileptic spasm syndrome onset: A prospective cohort study.
    Goswami I; Maguire B; Chau V; Tam EW; Pinchefsky E; Whitney R; Wilson D; Miller SP; Cortez MA
    Front Neurol; 2022; 13():1090155. PubMed ID: 36619920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic mechanisms of catastrophic epilepsy -- overview from animal models.
    Galanopoulou AS
    Brain Dev; 2013 Sep; 35(8):748-56. PubMed ID: 23312951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment modalities for infantile spasms: current considerations and evolving strategies in clinical practice.
    Hollenshead PP; Jackson CN; Cross JV; Witten TE; Anwar AI; Ahmadzadeh S; Shekoohi S; Kaye AD
    Neurol Sci; 2024 Feb; 45(2):507-514. PubMed ID: 37736852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.